Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled nitric oxide testing.

International journal of chronic obstructive pulmonary disease

Volumn 1, Issue 4, 2006, Pages 461-466

  Freiler, John F ^a   Arora, Rajiv ^a   Kelley, Thomas C ^a   Hagan, Larry ^a   Allan, Patrick F ^a  

^a USAF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; NITRIC OXIDE; SALBUTAMOL;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXHALATION; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY;

ADRENERGIC BETA-AGONISTS; AGED; AGED, 80 AND OVER; ALBUTEROL; EXHALATION; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 38449116181     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: 10.2147/copd.2006.1.4.461     Document Type: Article

References (0)